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oncardiac Abnormalities
n Diagnostic Cardiac
omputed Tomography
ithin Normal
imits or We Never Looked!*
ohn A. Rumberger, PHD, MD, FACC
ublin, Ohio
oncontrast cardiac computed tomography (electron beam
omography [EBT] and multidetector computed tomogra-
hy [MDCT]) for the definition of coronary artery calcium
core has been shown to be of value in defining individual-
zed cardiac risk, over and above population-based, conven-
ional risk factors (1,2). This is considered to be screening
y some clinicians and justified for refinement of individual
isk by others (3). Regardless, such imaging studies include
ll structures within the pericardium and at least a portion of
he surrounding lung, aorta, and chest—depending on the
hosen image reconstruction field of view. Because the
ntire chest is irradiated with such procedures, reconstruct-
ng images of the heart and then reconstructing images of
he chest as a whole provides no additional radiation to the
atient. Controversies abound about whether the lungs and
hest should be formally reviewed on these screening “heart
cans.” Although I have personal opinions about what
hould be done (which form the foundations for the
ubsequent discussion), they are not universally shared by
olleagues who also perform cardiac and cardiovascular
creening.
See page 402
Contrast-enhanced cardiac CT scans are becoming more
ommon, literally worldwide, as diagnostic tools after liter-
lly scores of studies (originally investigated and validated in
ermany [4] and in the U.S. [5] using EBT). As cardiac
T has become more sophisticated, the latest generation of
4-slice MDCT have now shown the greatest promise in
efining not only focal coronary stenoses but also calcified
nd noncalcified (6) plaque. Such studies are not done for
creening purposes, but as part of a diagnostic workup,
enerally in a patient with symptoms caused by a potential
ardiovascular origin or to clarify potential pathology from
ther tests (e.g., echocardiography, perfusion imaging, and
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From The Ohio State University, HealthWISE Wellness Diagnostic Center,t
ublin, Ohio. Dr. Rumberger has received a grant from the National Institutes of
ealth and is currently on the KOS Pharma Speakers Bureau.nvasive angiography). Because common symptoms such as
chest pain” and “shortness of breath” are not universally
ccounted for by purely cardiac causes, diagnostic contrast-
nhanced chest CT is often used as a “triple rule-out,” i.e.,
ooking for the three most deadly causes of such symp-
oms—myocardial ischemia/infarction, aortic dissection,
nd pulmonary embolism. Of course, because part of the
tructures are included in the radiation field, review of the
mages is needed for less immediately life-threatening, but
till important, associated diagnoses such as pneumonia,
iagrammatic hernia, and pericardial disease.
In the cases of the triple rule-out using contrast-enhanced
hest CT, it would be appropriate to include a team
pproach—using the interpretive skills of individuals
rained in cardiologic and radiographic imaging. However,
s the use of cardiac CT for a variety of purposes (using
BT or MDCT) grows (almost exponentially if the number
f “training” course offered by various professional societies
nd/or private concerns is a fair measure), it is not clear
hether the approach of reviewing the images for cardiac
nd noncardiac findings is being universally taught or
pplied in practice.
The paper in this issue of the Journal by Onuma et al. (7)
n defining noncardiac findings in cardiac CT brings these
ssues to the forefront. As a cardiovascular disease specialist,
have focused much of my professional career, spanning
ow more than 20 years, on the development of cardiac CT
nd its application to clinical practice. I have also had the
rivilege, as an admitted “interloper” in the world of
adiology, to sit beside and interact, cajole, learn, and be
uided by colleagues who were pioneers and remain leaders
n this application of radiological sciences. As such, I have
ome comments to make about looking “outside the box” of
he heart into the chest and adjacent structures to complete
he image review and to provide the best care to patients.
hese comments revolve around three aspects that are
nterrelated, but still separate: medico-legal, medico-moral,
nd medico-economic.
EDICO-LEGAL
unold et al. (8) in a “screening” population from Germany
ound that 53% of 1,812 patients had at least one noncardiac
nding using EBT. The current study by Onuma et al. (7)
ound the prevalence to be 58%, although 52% were either
urrent (13%) or former (39%) smokers. A study by Horton
t al. (9) looked at a screening population of 1,326 in
altimore and found a much lower incidence of pulmonary
bnormalities, with only 7.8% requiring clinical or radio-
ogic follow-up. In the latter study, only 25% of the cohort
ad a smoking history. However, the prevalence of active
mokers in Europe and Japan is not necessarily greater than
he current 24% in the U.S. (10). Additionally, the high
revalence of heart disease in the U.S. is especially impor-
ant in former smokers, and the potential for lung cancer
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Editorial Comment July 18, 2006:407–8evelopment is relatively high for at least 10 years (and
otentially up to 20 years) after cessation. Although in the
hort follow-up from the Onuma study only 8% (a total of
) had malignancies (2 lung cancers and 2 breast cancers),
he missing of even one cancer is clinically unacceptable.
dditionally, “failure to diagnose” remains one of the most
ommon issues in malpractice cases. Also of major clinical
mportance, Onuma et al. (7) showed that in 32 of 201
atients in whom coronary disease was ruled out, noncardiac
ndings by CT were considered sufficient to explain the
ymptoms.
EDICO-MORAL
cannot imagine that any cardiologist would look only at
he heart on a chest radiograph. It is the obligation of the
linician or the summation of the clinicians involved in any
edical case to ensure that all data available are reviewed.
f course, this may depend on the diagnostic capability of
he tests available. For instance, standard cardiac myocardial
erfusion imaging is simply not of sufficient quality to be
iagnostic of surrounding pulmonary structures. Thus, no
ccountability is expected for areas outside the target. The
ame can be said for other methods, such as echocardiog-
aphy and even cardiac catheterization. However, CT is
iagnostic. The required high-resolution, thin-sectioning
maging for contrast-enhanced cardiac CT is sufficient for
eneral noncardiac body diagnostics. It is thus the conten-
ion that medico-moral (obligatory) situations would impli-
ate viewing all images and areas irradiated as diagnostic of
otential pathology.
EDICO-ECONOMIC
here are a number of discussions related to the potential
edico-economic issues of screening. That is the situation
n which a heart scan was performed to define coronary
alcification and an incidental finding was a small pulmo-
ary nodule. Many academic discussions then define the
ownstream testing that might follow an obligatory workup
or that nodule. Most of these end up with the potential
cenario of biopsies being done on benign lesions. Such
tatements are generally hyperbole, just as the farcical
omments by some related to finding coronary calcium and
unnecessary” cardiac catheterizations. There are simply
o data to support these fanatical downstream economic
rojects that would ostensibly bankrupt the insurance
ompanies.
There are published guidelines on what to do with
ositive CT coronary calcium studies (11) that are almost
niversally applied, and there are also published guidelines
s to what to do with pulmonary nodules found in CT scans
erformed in smokers and nonsmokers (12). None of these
uidelines suggest cardiac catheterization or lung biopsy,
espectively, as an initial approach to abnormal studies. To
ut it simply, diagnostic imaging is just that: diagnostic; it
ay or may not require confirmation of other diagnosticodalities, but the responsible clinician will proceed with
uch workup in the most economical, but legal and moral,
anner. I often end my lectures that discuss cost effective-
ess with this poignant remark: “Cost effectiveness in
edicine often depends on whose life is being saved, mine
r somebody else’s.”
ONCLUSIONS
e all learned as medical students or residents the shortcut
o use in the medical record noting certain areas of the
hysical examination as WNL. Of course this was short-
and for within normal limits; however, with the expanding
ole of cardiovascular CT and radiation and imaging of both
he target areas as well as other structures, we simply cannot
olerate for legal, moral, and economic reasons to use the
ther meaning of within normal limits: we never looked.
eprint requests and correspondence: Dr. John A. Rumberger,
he Ohio State University, HealthWISE Wellness Diagnostic
enter, 5747 Perimeter Drive, Suite 105, Dublin, Ohio 43017.
-mail: jrumberger@healthwisecenter.com.
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